Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
&NA;
1996.
Paroxetine withdrawal.
Reactions Weekly,
Vol. &NA;,
Issue. 629,
p.
10.
Therrien, Fran�ois
and
Markowitz, John S.
1997.
Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature.
Human Psychopharmacology: Clinical and Experimental,
Vol. 12,
Issue. 4,
p.
309.
Young, A. H.
Currie, A.
and
Ashton, C. H.
1997.
Antidepressant withdrawal syndrome.
British Journal of Psychiatry,
Vol. 170,
Issue. 3,
p.
288.
Goldstein, Burton J.
and
Goodnick, Paul J
1998.
Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics.
Journal of Psychopharmacology,
Vol. 12,
Issue. 4_suppl,
p.
55.
Haddad, Peter
1998.
The SSRI discontinuation syndrome.
Journal of Psychopharmacology,
Vol. 12,
Issue. 3,
p.
305.
Rajagopalan, Mani
and
Little, John
1999.
Discontinuation Symptoms with Nefazodone.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
594.
Rajagopalan, Mani
and
Little, John
1999.
Discontinuation Symptoms with Nefazodone.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
594.
Haddad, Peter M.
2001.
Antidepressant Discontinuation Syndromes.
Drug Safety,
Vol. 24,
Issue. 3,
p.
183.
Bogetto, Filippo
Bellino, Silvio
Revello, Raffaele Bonatto
and
Patria, Luca
2002.
Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors.
CNS Drugs,
Vol. 16,
Issue. 4,
p.
273.
Judge, R.
Parry, M.G.
Quail, D.
and
Jacobson, J.G.
2002.
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
International Clinical Psychopharmacology,
Vol. 17,
Issue. 5,
p.
217.
Yáñez, Luis Pacheco
Malo, Pablo
Etxebeste, María
Aragües, Enrique
and
Medrano, Juan
2003.
New Dosage-Reduction Regime to Avoid Paroxetine Discontinuation Syndrome.
The Canadian Journal of Psychiatry,
Vol. 48,
Issue. 2,
p.
129.
Martin, Richard M.
May, Margaret
and
Gunnell, David
2006.
Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004.
British Journal of Clinical Pharmacology,
Vol. 61,
Issue. 2,
p.
224.
Haddad, Peter M.
and
Anderson, Ian M.
2007.
Recognising and managing antidepressant discontinuation symptoms.
Advances in Psychiatric Treatment,
Vol. 13,
Issue. 6,
p.
447.
Fava, Giovanni A.
Gatti, Alessia
Belaise, Carlotta
Guidi, Jenny
and
Offidani, Emanuela
2015.
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
Psychotherapy and Psychosomatics,
Vol. 84,
Issue. 2,
p.
72.
Quilichini, Jean-Baptiste
Revet, Alexis
Garcia, Philippe
Bouquié, Régis
Hamard, Jacques
Yrondi, Antoine
and
Montastruc, François
2022.
Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: A real-world study using the WHO pharmacovigilance database.
Journal of Affective Disorders,
Vol. 297,
Issue. ,
p.
189.
Horowitz, Mark Abie
Framer, Adele
Hengartner, Michael P.
Sørensen, Anders
and
Taylor, David
2023.
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.
CNS Drugs,
Vol. 37,
Issue. 2,
p.
143.
eLetters
No eLetters have been published for this article.